<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">493</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 468.300 L105.610 468.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,67.861,74.359,79.363,84.079,87.076,88.912,91.414,95.914,100.414,104.914,108.91,112.906,117.406,119.242,123.742,127.738,131.734,134.236,138.736,140.572,145.072,148.069,149.905,155.404,159.904,164.404,168.904,170.74,174.736,178.732,181.234,183.736,185.572,188.074,190.576,195.076,199.072,201.322,203.158,209.161,212.158,214.66,218.656,221.653,224.155,228.07,230.32,232.156,236.656,241.156,245.656,248.158,255.16,257.662,259.498,263.998,266.995,268.831,271.828,276.328,281.827,288.325,293.329,298.045" svgx:width="0.61,0.72,0.56,0.52,0.33,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.44,0.44,0.28,0.5,0.25,0.5,0.33,0.25,0.61,0.5,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.25,0.28,0.28,0.5,0.44,0.25,0.25,0.67,0.33,0.28,0.44,0.33,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.78,0.28,0.25,0.5,0.33,0.25,0.33,0.5,0.61,0.72,0.56,0.52,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TNFα- induced death of L929 cell line. Briefly, 1ng/ml of rhTNFα </text>
   <text y="88.101" x="62.362,68.86,72.856,76.357,78.427,80.929,85.429,89.425,93.925,98.425,102.421,104.923,108.919,113.419,115.489,121.987,124.489,126.991,131.491,133.561,136.063,142.561,147.061,149.131,152.128,156.628,159.13,163.63,165.7,170.2,172.702,175.204,179.704,182.206,184.708,189.208,193.708,197.209,199.279,203.779,206.776,208.846,212.347,216.343,219.34,223.336,225.406,228.403,231.4,235.9,242.902,244.972,249.472,253.972,258.472,262.972,265.969,269.47,271.54,274.537,279.037,282.034,284.104,288.604,293.104,295.741,297.991" svgx:width="0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.72,0.5,0.25,0.33,0.5,0.28,0.5,0.25,0.5,0.28,0.28,0.5,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.39,0.44,0.33,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.5,0.5,0.33,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was incubated with two fold dilutions of sera from donors for 2hr, </text>
   <text y="99.099" x="62.362,66.862,71.362,74.962,80.965,83.215,85.762,91.261,95.761,99.757,104.257,106.507,109.216,113.716,118.216,123.04,125.542,128.044,134.542,138.538,141.04,143.542,146.251,150.751,153.748,156.457,158.959,163.459,167.455,170.164,173.665,177.661,180.658,185.158,192.16,195.157,198.154,202.654,208.153,214.651,219.655,224.371,227.08,234.082,236.584,241.084,245.08,249.58,252.289,255.79,260.29,262.792,267.292,269.794,272.296,276.796,281.296,284.005,290.503,294.499,298.0" svgx:width="0.5,0.5,0.4,0.67,0.25,0.25,0.61,0.5,0.44,0.5,0.25,0.25,0.5,0.5,0.54,0.28,0.28,0.72,0.44,0.28,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.78,0.33,0.33,0.5,0.61,0.72,0.56,0.52,0.25,0.78,0.28,0.5,0.44,0.5,0.25,0.39,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">37°C. Then, 50µl/well of the serum-rhTNFα mixed solution was </text>
   <text y="110.097" x="62.362,66.358,70.858,75.358,79.354,83.854,86.104,87.994,90.496,94.996,97.246,99.136,101.638,106.138,110.134,112.384,114.274,118.27,122.266,124.768,127.27,130.771,133.021,135.271,137.161,143.659,146.161,148.663,153.163,157.663,162.487,166.987,169.489,176.491,178.993,181.243,182.638,189.136,193.132,195.634,198.136,202.636,207.136,214.138,218.638,222.634,225.136,229.636,231.886,233.776,240.274,242.524,244.774,246.664,249.661,254.161,257.158,259.408,261.298,265.798,270.298,274.294,277.291,281.791,284.293,288.793,293.293,295.795,298.045" svgx:width="0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.72,0.28,0.28,0.5,0.5,0.54,0.5,0.28,0.78,0.28,0.25,0.55,0.72,0.44,0.28,0.28,0.5,0.5,0.78,0.5,0.44,0.28,0.5,0.25,0.55,0.72,0.25,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">added to the cells, with1µg/ml Actinomycin D, for overnight, </text>
   <text y="121.095" x="62.362,66.862,71.362,74.962,80.965,83.215,86.041,90.541,98.038,100.864,106.867,113.365,117.865,120.115,122.941,128.944,132.94,135.442,137.944,141.445,144.271,147.772,152.272,155.269,159.769,162.271,166.771,170.767,173.269,176.095,182.593,186.589,190.09,192.916,196.912,201.412,205.408,212.41,214.912,219.412,223.408,227.908,230.734,235.234,239.734,242.56,249.058,254.557,259.894,262.72,266.716,270.217,273.718,277.714,282.214,285.04,289.036,293.536,298.036" svgx:width="0.5,0.5,0.4,0.67,0.25,0.25,0.5,0.83,0.25,0.67,0.72,0.5,0.25,0.25,0.67,0.44,0.28,0.28,0.39,0.25,0.39,0.5,0.33,0.5,0.28,0.5,0.44,0.28,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.72,0.61,0.61,0.25,0.44,0.39,0.39,0.44,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">37°C, 5% CO2. Cells survival was examined by XTT assay and </text>
   <text y="132.093" x="62.362,68.86" svgx:width="0.72,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">OD</text>
   <text y="134.173" x="75.358,78.283,81.208,84.133,87.058" svgx:width="0.5,0.5,0.5,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">450nm</text>
   <text y="132.103" x="91.609,93.697,100.699,104.695,108.691,112.192,116.692,119.689,123.685,130.687,134.683,139.183,141.685,143.935,145.861,151.36,157.858,162.862,167.578,169.666,174.166,178.162,182.662,185.164,188.161,192.157,194.659,197.161,201.157,205.153,207.655,210.157,214.657,219.157,221.245,227.743,231.739,235.24,237.328,241.324,245.32,247.822,251.818,256.318,258.82,262.816,265.318,269.314,273.814,275.902,280.402,284.902,286.99,289.492,293.992,297.988" svgx:width="0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.78,0.44,0.5,0.28,0.25,0.25,0.61,0.72,0.56,0.52,0.25,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.44,0.28,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> measurement. TNFα neutralization was calculated by the </text>
   <text y="143.101" x="62.359,66.859,70.855,73.852,77.848,81.844,86.344,88.846,92.842,97.342,101.338,103.525,108.025,111.022,113.209,117.709,120.211,124.711,128.707,133.207,137.203,141.703,145.699,147.886,152.386,155.383,157.57,160.072,164.572,168.568,170.593,176.092,182.59,187.594,192.31,194.497,198.997,201.499,204.001,206.503,209.005,213.505,218.005,220.192,224.188,227.023,230.02,234.016,238.012,240.514,242.701,247.201,251.701,253.888,256.39,260.89,264.886,267.073,271.069,275.065,277.567,280.069,282.256,284.758,287.26,291.76,295.756,298.006" svgx:width="0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.28,0.5,0.44,0.5,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.61,0.72,0.56,0.52,0.25,0.5,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.28,0.28,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">percentage of blockade of the TNFα killing effect on the cell line. </text>
   <text y="154.099" x="62.359,67.363,71.359,74.356,78.856,85.858,88.108,88.909,91.411,95.407,99.907,103.903,106.405,109.906,112.156,112.957,117.457,120.454,122.704,123.505,128.005,130.507,135.007,139.507,142.009,146.509,151.009,153.259,154.06,158.056,162.556,165.058,167.56,170.557,176.056,182.554,187.558,192.274,194.524,195.325,201.823,205.819,208.816,212.812,215.062,215.863,219.364,221.866,226.366,230.866,233.368,237.364,241.864,244.114,244.915,249.415,253.915,256.16499999999996,256.966,262.465,267.964,270.961,275.965,281.968,284.218,285.019,289.015,293.515,298.015" svgx:width="0.56,0.44,0.33,0.5,0.78,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.61,0.72,0.56,0.52,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.61,0.33,0.56,0.72,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Serum levels of binding anti-TNFα were studied by ELISA and </text>
   <text y="165.097" x="62.359,66.355,69.352,73.348,75.598,79.594,84.094,88.594,91.591,95.587,99.088,102.589,106.585,111.085,113.335,115.837,120.337,122.587,129.085" svgx:width="0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are expressed in OD</text>
   <text y="167.173" x="135.585,138.51,141.435,144.36,147.285" svgx:width="0.5,0.5,0.5,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">450nm</text>
   <text y="165.103" x="151.836" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">.</text>
   <text y="176.101" x="62.358,69.036,73.212,76.893,82.077,84.759,87.936,91.617,94.794" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="176.101" x="97.512,102.696,106.872,110.049,114.225,116.943,121.623,124.8,127.518,132.198,136.878,139.56,142.737,146.913,151.089,153.771,157.947,162.627,165.345,171.528,177.711,185.892,191.076,193.794,198.474,202.65,205.332,208.014,212.19,216.87,219.552,223.233,225.951,230.631,234.807,239.487,242.205,246.381,249.099,253.779,256.461,261.141,265.821,269.997,273.174,275.73,281.409,288.087,293.271,297.987" svgx:width="0.56,0.44,0.33,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.61,0.72,0.56,0.52,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Sera of untreated RRMS patients had a higher TNFα </text>
   <text y="187.099" x="62.358,67.038,71.214,75.894,78.576,81.753,85.929,88.611,91.293,95.469,99.645,102.327,105.009,109.689,114.369,117.231,121.407,125.583,130.263,134.439,138.615,141.297,143.979,148.659,151.521,155.697,159.378,162.24,166.416,171.096,178.278,182.958,187.134,190.311,194.487,199.167,202.029,204.711,209.391,212.253,218.931,225.114,227.544,230.406,235.59,240.27,243.447,246.309,249.99,254.166,257.343,262.023,269.205,272.067,274.749,277.431,280.113,284.289,287.466,290.328,295.008,298.005" svgx:width="0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.67,0.25,0.25,0.56,0.5,0.33,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.28,0.28,0.28,0.44,0.33,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neutralization capacity as compared to HC. For serum titer of </text>
   <text y="198.097" x="62.358,67.038,69.72,74.4,76.65,78.783,81.465,86.145,90.321,92.571,94.704,98.88,103.56,107.736,110.913,115.089,119.769,123.945,126.195,128.328,133.008,136.185,138.435,140.568,145.248,149.424,154.104,156.786,159.963,164.139,166.821,169.503,173.679,177.855,180.537,183.219,187.899,192.579,194.829,196.962,201.642,204.819,207.069,209.04,214.719,221.397,226.581,231.477,233.727,235.86,240.54,243.222,245.904,248.586,251.268,255.948,260.628,262.878,265.011,269.187,272.202,275.379,279.555,283.731,286.413,288.663,290.796,293.478,297.978" svgx:width="0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1:8 the average of neutralization of TNFα killing effect in </text>
   <text y="209.095" x="62.358,67.038,71.718,74.4,77.577,81.753,85.929,88.611,92.787,97.467,99.717,102.543,108.726,114.909,123.09,128.274,130.524,133.35,140.028,144.204,147.885,150.135,152.961,157.641,162.321,164.751,169.431,174.552,179.232,183.912,186.342,191.022,198.699,200.949,203.775,208.455,212.136,214.566,216.816,219.642,224.322,229.002,231.432,236.112,241.233,245.913,250.593,253.023,257.703,265.38,267.63,270.456,273.138,277.818,280.068,282.894,289.572,295.755,298.005" svgx:width="0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.67,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">untreated RRMS was 57.8±20.8% vs. 32.4±20.6% in HC, </text>
   <text y="220.093" x="62.358,67.038,72.294,76.974,79.404,84.084,88.764,93.444,95.874,98.124,99.996,105.18,109.86,113.037,115.287,117.159,119.841,122.523,125.205,129.381,132.558,134.808,136.68,141.36,144.537,146.787,148.659,153.339,156.021,160.701,165.381,167.631,169.503,172.185,176.865,181.041,183.291,185.163,189.339,194.019,198.195,201.372,205.548,210.228,214.404,218.085,220.335,222.207,226.887,230.064,232.314,234.186,238.866,243.042,247.722,250.404,253.581,257.757,260.439,263.121,267.297,271.473,274.155,276.837,281.517,286.197,288.447,290.319,294.999,297.996" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.5,0.33,0.25,0.55,0.28,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.5,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.025. For titer of 1:16 the averages of neutralization of </text>
   <text y="231.091" x="62.358,68.037,74.715,79.899,84.795,87.045,88.395,92.571,95.586,98.763,102.939,107.115,109.797,112.047,113.397,120.075,124.251,127.428,131.604,133.854,135.204,139.884,144.564,146.994,151.674,156.795,161.475,166.155,168.585,173.265,180.942,183.192,184.542,189.222,192.903,195.333,197.583,198.933,203.613,208.293,210.723,215.403,220.524,225.204,229.884,232.314,236.994,244.671,247.101,249.351,250.701,253.878,258.054,261.735,266.415,270.591,274.767,277.449,280.131,284.811,288.987,291.669,295.764,298.014" svgx:width="0.61,0.72,0.56,0.52,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TNFα effect were 51.0±19.3% vs. 22.4±22.5%, respectively, </text>
   <text y="242.089" x="62.358,67.038,72.294,76.974,79.404,84.084,88.764,93.444,95.874,98.124,101.337,105.513,110.193,114.873,117.123,120.336,123.513,128.193,131.37,133.62,136.833,139.515,142.197,144.879,149.055,152.232,154.482,157.695,162.375,165.057,169.737,174.417,177.099,179.349,182.562,187.242,191.922,194.352,199.032,204.153,208.833,213.513,215.943,220.623,228.3,230.55,233.763,238.443,242.124,244.554,246.804,250.017,254.697,259.377,261.807,266.487,271.608,276.288,280.968,283.398,288.078,295.755,298.005" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.017, and for titer 1:32: 36.4±12.8% vs. 21.7±16.1%, </text>
   <text y="253.087" x="62.358,67.038,72.294,76.974,79.404,84.084,88.764,91.194,93.444,95.406,98.583,103.263,105.513,107.475,110.652,115.836,122.514,127.275,131.955,136.131,138.381,140.343,143.025,146.202,150.378,154.554,157.236,161.412,166.092,168.342,170.304,174.984,179.16,181.842,184.524,188.7,193.38,196.062,199.743,201.993,203.955,206.637,211.317,215.493,217.743,219.543,225.222,231.9,237.084,241.98,244.23,246.192,250.872,255.048,259.728,262.41,265.587,269.763,272.445,275.127,279.303,283.479,286.161,288.843,293.523,298.023" svgx:width="0.5,0.56,0.5,0.25,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.33,0.56,0.72,0.51,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">p=0.05. In IFNβ1a treated patients the TNFα neutralization </text>
   <text y="264.085" x="62.358,66.534,70.71,75.39,79.566,83.742,86.424,89.106,93.786,96.036,97.233,103.911,108.087,111.768,114.018,115.215,118.896,121.578,128.76,131.442,134.124,138.3,141.477,143.727,144.924,147.606,152.286,154.536,155.733,162.411,168.594,171.024,173.274,174.471,178.647,181.077,185.757,188.007,189.204,192.381,197.061,200.238,202.488,203.685,206.367,209.049,211.731,215.907,219.084,221.334,222.531,227.211,229.893,234.573,239.253,241.503,242.7,245.382,250.062,254.238,256.488,257.685,261.861,266.541,270.717,273.894,278.07,282.75,286.926,289.176,290.373,295.053,298.05" svgx:width="0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.67,0.25,0.25,0.55,0.44,0.25,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.28,0.28,0.44,0.33,0.25,0.55,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">capacity was similar to HC, e.g for titer 1:32 the average of </text>
   <text y="275.083" x="62.358,67.038,71.214,75.894,78.576,81.753,85.929,88.611,91.293,95.469,99.645,102.327,105.009,109.689,114.369,116.619,118.815,123.495,126.672,128.922,130.956,136.635,143.313,148.497,153.393,155.643,157.839,162.015,165.03,168.207,172.383,176.559,179.241,181.491,183.687,190.365,194.541,198.222,200.472,202.668,207.348,212.028,214.458,219.138,224.259,228.939,233.619,236.049,240.729,248.406,250.836,253.086,255.282,259.962,265.218,269.898,272.328,277.008,281.688,286.368,288.618,290.814,293.496,297.996" svgx:width="0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.72,0.56,0.52,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neutralization of TNFα effect was 20.4±19.0%, p=0.027 in </text>
   <text y="286.081" x="62.358,66.534,71.214,78.396,83.076,87.252,90.429,93.111,96.792,101.472,106.152,108.402,109.563,112.245,116.925,119.175,120.336,125.016,129.696,132.378,135.555,139.731,143.907,146.589,150.765,155.445,157.695,158.856,163.536,167.712,170.394,173.076,177.252,181.932,184.614,188.295,190.725,192.975,193.974,199.653,204.333,208.509,210.759,211.92,216.096,220.776,223.458,226.14,229.317,234.996,241.674,246.858,251.754,254.004,255.165,259.845,262.527,267.207,271.887,274.569,279.249,283.929,286.845,293.523,298.023" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">comparison to untreated patients. The anti-TNFα binding Ab </text>
   <text y="297.079" x="62.358,65.04,69.216,73.896,78.072,80.754,84.435,86.685,87.666,94.344,98.52,101.697,105.873,108.123,109.104,113.784,116.466,121.146,125.826,130.002,133.179,135.429,136.41,139.092,143.772,146.022,147.003,153.681,159.864,162.114,163.095,166.272,170.952,173.382,178.062,182.742,187.422,192.543,197.223,199.653,204.333,209.013,213.693,216.87,219.12,220.101,224.781,228.462,230.892,233.142,234.123,238.803,243.483,246.165,249.342,253.518,257.694,260.376,264.552,269.232,271.482,272.463,278.646,284.829,293.01,298.014" svgx:width="0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.67,0.25,0.55,0.33,0.5,0.25,0.5,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">levels were higher in HC (0.545±0.209) vs. untreated RRMS </text>
   <text y="308.077" x="62.358,65.535,70.215,72.645,77.325,82.005,86.685,91.806,96.486,98.916,103.263,107.943,112.623,115.053,117.303,121.839,126.519,131.775,136.455,138.885,143.565,148.245,152.925,156.102,158.352,162.888,167.064,171.744,176.424,178.674,183.21,187.89,191.571,194.001,196.251,200.787,203.964,209.148,215.826,220.587,225.267,229.443,231.693,236.229,238.911,242.088,246.264,250.44,253.122,257.298,261.978,264.228,268.764,273.444,277.62,280.302,282.984,287.16,291.84,294.522,298.023" svgx:width="0.33,0.5,0.25,0.5,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.39,0.25,0.25,0.55,0.33,0.56,0.72,0.51,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(0.436±0.118, p=0.021) and vs. IFNβ1a treated patients </text>
   <text y="319.075" x="62.358,65.535,70.215,72.645,77.325,82.005,86.685,91.806,96.486,98.916,103.596,108.276,112.956,115.386,117.816,122.496,127.752,132.432,134.862,139.542,144.222,148.902,152.079" svgx:width="0.33,0.5,0.25,0.5,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(0.372±0.097, p=0.037).</text>
   <text y="330.073" x="62.358,68.856,73.356,78.36,82.356,84.858,89.862,93.363,95.865,100.365,105.369,108.87,111.867" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="330.073" x="115.287,120.786,127.284,132.288,137.004,139.254,140.424,144.924,148.92,153.42,155.922,158.919,162.915,165.417,167.919,171.915,175.911,178.413,180.915,185.415,189.915,192.165,193.335,195.837,199.338,201.588,202.758,207.258,211.758,216.258,222.756,227.256,229.506,230.676,233.178,237.678,239.928,241.098,243.6,248.1,252.6,257.1,261.096,265.092,267.342,268.512,276.513,281.517,284.514,287.016,289.518,294.018,298.014" svgx:width="0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.55,0.89,0.56,0.33,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TNFα neutralization is known to induce MS-like </text>
   <text y="341.071" x="62.358,64.86,68.856,72.357,74.859,79.359,83.859,87.36,89.61,91.257,99.033,103.029,104.847,107.844,112.344,116.844,121.344,125.844,127.653,130.155,134.655,138.651,141.153,142.971,147.471,151.971,154.473,157.47,161.466,165.462,167.964,171.96,176.46,178.269,184.272,190.275,198.276,203.28,205.089,209.589,213.585,216.087,218.589,222.585,227.085,229.587,233.088,234.906,239.406,243.402,247.902,251.898,253.707,257.703,262.203,264.021,266.523,271.023,275.019,278.016,282.012,286.008,289.509,293.505,298.005" svgx:width="0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.25,0.94,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lesions. We found that untreated RRMS patients have an increased </text>
   <text y="352.069" x="62.358,67.857,74.355,79.359,84.075,86.325,87.216,91.716,95.712,100.212,102.714,105.711,109.707,112.209,114.711,118.707,122.703,125.205,127.707,132.207,136.707,138.957,139.848,143.844,147.84,152.34,156.336,160.332,162.834,165.336,169.251,171.501,173.751,174.48,179.979,184.479,188.475,191.976,195.972,198.222,199.113,202.11,204.612,209.112,213.612,216.114,220.614,225.114,227.364,228.255,231.756,236.256,240.756,245.256,249.252,252.753,255.255,257.505,258.396,260.898,265.398,269.394,271.896,274.146,275.037,279.537,282.039,286.539,290.535,295.035" svgx:width="0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">TNFα neutralization capacity. These finding suggest that block-</text>
   <text y="363.067" x="62.358,66.354,70.854,74.85,76.92,81.42,84.417,86.325,91.824,98.322,103.326,108.042,110.112,113.613,116.115,120.615,125.115,129.111,131.613,134.115,138.615,143.115,145.185,152.187,156.183,160.683,162.753,167.253,169.755,173.751,178.251,180.321,184.317,186.387,189.384,193.884,196.386,200.382,202.452,204.954,209.454,211.524,214.026,218.526,222.522,224.592,229.092,233.088,235.59,240.09,244.59,249.09,253.086,257.586,261.582,265.083,267.585,271.086,273.156,277.656,280.653,282.723,290.724,295.728,297.978" svgx:width="0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.61,0.72,0.56,0.52,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.78,0.44,0.5,0.25,0.5,0.28,0.44,0.5,0.25,0.44,0.25,0.33,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ade of TNFα signaling may play a role in the pathogenesis of MS. </text>
   <text y="374.065" x="62.358,68.856,73.356,75.606,76.371,80.367,84.867,87.864,90.861,94.857,97.359,101.355,103.857,106.359,110.859,115.359,117.609,118.374,124.872,128.868,132.369,134.619,135.384,138.381,142.881,147.381,151.881,156.381,158.631,159.396,163.896,167.892,170.394,176.892,180.888,184.884,189.384,191.634,192.399,194.901,199.401,203.397,205.647,206.412,209.913,213.909,216.906,220.902,223.755,229.254,235.752,240.756,245.472,247.722,248.487,252.987,256.983,261.483,263.985,266.982,270.978,273.48,275.982,279.978,283.974,286.476,288.978,293.478,297.978" svgx:width="0.72,0.5,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.33,0.44,0.25,0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">No correlation was found between the sera TNFα neutralization </text>
   <text y="385.063" x="62.358,66.354,70.35,74.85,78.846,82.842,85.344,87.846,92.346,94.677,98.673,103.173,107.673,110.004,112.506,117.006,121.002,123.333,125.835,129.831,134.331,138.327,140.829,144.33,146.661,151.161,154.158,156.489,160.485,164.985,167.487,169.989,172.158,177.657,184.155,189.159,193.875,196.206,200.706,203.208,207.708,212.208,214.71,219.21,223.71,225.546,232.044,236.544,238.794,241.125,244.122,249.126,255.624,260.205,264.705,268.701,271.032,273.534,278.034,282.03,285.027,289.023,293.523,298.023" svgx:width="0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.25,0.61,0.72,0.56,0.52,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.72,0.5,0.25,0.25,0.33,0.56,0.72,0.51,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">capacity and the levels of anti TNFα binding Ab. IFNβ1a therapy </text>
   <text y="396.061" x="62.358,66.858,71.358,74.355,81.357,85.353,87.855,90.357,94.353,98.349,102.849,105.099,106.863,109.365,113.865,117.861,120.111,121.713,127.212,133.71,138.714,143.43,145.68,147.444,151.944,155.94,160.44,162.942,165.939,169.935,172.437,174.939,178.935,182.931,185.433,187.935,192.435,196.935,199.185,200.949,204.945,208.941,213.441,217.437,221.433,223.935,226.437,230.352,232.602,234.852,236.454,241.953,246.453,248.955,252.456,254.706,256.47,258.972,262.473,264.723,266.487,270.483,274.983,277.233,278.997,283.497,287.997,290.994,294.99" svgx:width="0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.61,0.72,0.56,0.52,0.25,0.55,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">normalized the TNFα neutralization capacity. This is an unre-</text>
   <text y="407.059" x="62.358,66.858,71.358,74.355,76.857,80.853,85.353,87.603,94.605,99.105,103.605,107.601,109.851,114.351,117.348,119.598,123.594,127.59,130.092,132.594,137.094,141.594,143.844,148.344,151.341,153.591,156.588,161.592,168.09,172.671,177.171,181.167" svgx:width="0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.78,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.56,0.72,0.51,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ported mode of action of IFNβ1a.</text>
   <text y="434.059" x="62.358,67.857,72.357,76.857" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P975</text>
   <text y="445.057" x="62.358,68.856,73.356,76.353,80.853,83.355,85.857,89.853,94.857,102.354,106.854,111.858,114.108,116.61,121.614,125.61,129.606,133.602,138.102,141.603,145.599,149.1,151.35,158.352,164.355,170.853,173.85,180.852,183.102,187.098,191.598,196.602,200.598,204.594,208.095,211.596,214.098,218.598,223.602,225.852,228.354,233.358,235.608,241.107,247.605,254.103,257.604,259.854,264.354,267.351" svgx:width="0.72,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.28,0.56,0.44,0.44,0.44,0.5,0.39,0.44,0.39,0.25,0.78,0.67,0.72,0.33,0.78,0.25,0.44,0.5,0.56,0.44,0.44,0.39,0.39,0.28,0.5,0.56,0.25,0.28,0.56,0.25,0.61,0.72,0.72,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Natalizumab increases HLA-G expression in PDCs of </text>
   <text y="456.055" x="62.358,69.855,74.859,77.361,80.358,82.86,87.864,90.366,94.362,96.612,100.113,104.109,106.611,110.607,114.603,119.103,122.604,125.106,128.607,130.857,135.861,140.361,143.358,145.86,149.856,154.86,157.857" svgx:width="0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">multiple sclerosis patients</text>
   <text y="467.053" x="62.358,68.856,74.859,77.109,83.607,86.109,90.609,95.109,99.105,101.607" svgx:width="0.72,0.67,0.25,0.72,0.28,0.5,0.5,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AC Dionete</text>
   <text y="464.583" x="105.607" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="108.532,110.782,113.032,119.53,124.534,126.784,134.785,139.285,142.282,146.278,150.274" svgx:width="0.25,0.25,0.72,0.56,0.25,0.89,0.5,0.33,0.44,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AS Moraes</text>
   <text y="464.583" x="153.774" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="156.699,158.949,161.199,169.2,171.45,177.948,182.448,189.45,191.952,196.452,200.952,205.452,209.448,212.949,215.199,219.699,223.695,225.945,232.443,236.943,241.443,244.44,248.436,252.936" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5,0.78,0.28,0.5,0.5,0.5,0.44,0.39,0.25,0.5,0.44,0.25,0.72,0.5,0.5,0.33,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Domingues de Andrade</text>
   <text y="464.583" x="256.931" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="259.856,262.106" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="478.101" x="62.36,68.363,70.613,77.111,81.107,88.109,92.105,95.606,99.602,103.598,108.098" svgx:width="0.67,0.25,0.72,0.44,0.78,0.44,0.39,0.44,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B Damasceno</text>
   <text y="475.583" x="112.599" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="115.524,117.774,120.024,126.522,128.772,135.27,139.266,146.268,150.264,153.765,157.761,161.757,166.257" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.78,0.44,0.39,0.44,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Damasceno</text>
   <text y="475.583" x="170.757" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="173.682,175.932,178.182,184.185,186.435,192.438,196.434,199.431,203.931,207.927,210.429,213.426" svgx:width="0.25,0.25,0.67,0.25,0.67,0.44,0.33,0.5,0.44,0.28,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Carneiro</text>
   <text y="475.583" x="217.925" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="220.85,223.1,225.35,228.851,231.101,237.599,244.601" svgx:width="0.25,0.25,0.39,0.25,0.72,0.78,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Amm</text>
   <text y="475.583" x="251.603" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="254.528,256.778,259.028,265.031,270.035" svgx:width="0.25,0.25,0.67,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CP </text>
   <text y="489.101" x="62.36,67.859,70.361,72.863,77.363,81.359,84.356" svgx:width="0.61,0.28,0.28,0.5,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Tilbery</text>
   <text y="486.583" x="88.858" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="91.783,94.033,96.283,102.286,108.784,111.034,117.037,120.034,124.03,128.53,133.03,137.026" svgx:width="0.25,0.25,0.67,0.72,0.25,0.67,0.33,0.44,0.5,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, CO Brandão</text>
   <text y="486.583" x="141.525" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="144.45,146.7,148.95,155.448,160.452,162.702,167.706,171.702,174.699,177.201,181.197" svgx:width="0.25,0.25,0.72,0.56,0.25,0.56,0.44,0.33,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, AS Farias</text>
   <text y="486.583" x="184.698" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="187.623,189.873,192.123,197.127,203.625,205.875,212.373,214.875,218.871,223.371" svgx:width="0.25,0.25,0.56,0.72,0.25,0.72,0.28,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, FV Glehn</text>
   <text y="486.583" x="227.87" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="230.795,233.045,235.295,240.794,248.795,254.798,257.048,262.052,266.048,270.548,273.05,277.55" svgx:width="0.25,0.25,0.61,0.89,0.67,0.25,0.56,0.44,0.5,0.28,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, LMB Santos</text>
   <text y="486.583" x="281.051" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="497.581" x="62.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="500.103" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,120.286,124.786,131.284,135.784,138.286,142.786,147.286,150.787,153.037,156.034,162.532,168.535,171.532,177.535,183.034,190.531,196.03,199.027,201.277,203.527,210.025,214.021,218.521,221.023,223.273,225.523,232.021,236.017,240.517,244.513,247.015,249.517,253.513,257.014,259.264,261.514,267.013,271.009,275.509,278.011,282.511,285.013,287.515,292.015,296.515" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.67,0.5,0.72,0.5,0.28,0.5,0.5,0.39,0.25,0.33,0.72,0.67,0.33,0.67,0.61,0.83,0.61,0.33,0.25,0.25,0.72,0.44,0.5,0.28,0.25,0.25,0.72,0.44,0.5,0.44,0.28,0.28,0.44,0.39,0.25,0.25,0.61,0.44,0.5,0.28,0.5,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Campinas (UNICAMP), Dept. Genetics, Evolution </text>
   <text y="511.101" x="62.362,66.862,71.362,75.862,78.112,83.611,86.113,90.613,95.113,99.613,103.609,108.109,110.611,114.112,116.362,120.862,125.362,129.862,132.112,138.61,142.606,147.106,149.608,151.858,154.108,160.111,164.107,168.607,172.108,176.608,179.11,183.61,188.11,192.106,194.356,196.606,202.609,207.109,213.607,218.107,220.609,225.109,229.609,233.11,235.36,237.61,243.109,246.61,251.11,254.611,257.113" svgx:width="0.5,0.5,0.5,0.25,0.61,0.28,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.5,0.25,0.72,0.44,0.5,0.28,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.67,0.5,0.72,0.5,0.28,0.5,0.5,0.39,0.25,0.25,0.61,0.39,0.5,0.39,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">and Bioagents and Dept. Neurology, Campinas, Brazil</text>
   <text y="538.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="538.101" x="115.183,123.184,127.684,130.186,132.688,135.19,139.69,142.192,146.188,148.663,152.164,156.16,158.662,162.658,165.655,170.155,173.656,176.158,179.659,182.134,185.131,193.132,198.136,201.133,203.608,206.11,209.611,212.086,214.588,219.088,223.084,225.559,232.561,237.061,240.562,243.064,245.539,249.535,254.035,261.037,268.039,272.539,277.039,279.514,283.51,288.01,290.512,295.012" svgx:width="0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.78,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multiple sclerosis (MS) is the most common auto-</text>
   <text y="549.099" x="62.362,64.864,71.866,78.868,83.368,87.868,91.864,94.357,98.857,101.359,104.86,108.856,112.852,116.353,120.349,122.842,127.342,130.339,132.832,135.334,139.834,143.83,146.323,150.319,154.315,158.815,161.317,164.314,168.31,170.812,173.305,177.805,181.801,184.798,189.298,193.798,198.298,201.799,204.292,207.793,212.293,215.794,218.296,222.292,229.294,231.787,234.784,240.787,247.285,252.289,255.286,257.536,260.029,268.03,273.034,275.527,279.028,283.528,290.53,295.03" svgx:width="0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.5,0.5,0.39,0.25,0.39,0.5,0.39,0.28,0.44,0.78,0.25,0.33,0.67,0.72,0.56,0.33,0.25,0.25,0.89,0.56,0.25,0.39,0.5,0.78,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immune disease of the central nervous system (CNS). MS symp-</text>
   <text y="560.097" x="62.362,64.864,69.364,76.366,79.867,82.666,86.662,89.659,93.655,96.454,100.45,104.95,109.45,112.951,116.947,121.447,125.947,129.943,134.443,138.439,142.435,145.234,148.231,151.228,155.728,162.73,165.529,168.031,172.531,175.033,179.029,182.026,185.023,189.523,194.023,196.525,199.027,203.527,208.027,210.826,215.326,218.323,221.122,225.622,229.618,232.615,237.115,241.111,243.91,246.412,253.414,257.914,262.414,264.916,268.417,272.413,275.212,279.712,284.212,287.011,289.513,294.013,298.009" svgx:width="0.28,0.5,0.78,0.39,0.25,0.44,0.33,0.44,0.25,0.44,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.28,0.44,0.33,0.33,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.33,0.5,0.44,0.25,0.28,0.78,0.5,0.5,0.28,0.39,0.44,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">toms are consequence from interruption of nerve impulse on the </text>
   <text y="571.095" x="62.362,69.364,73.864,77.86,80.362,82.864,87.364,91.36,93.862,97.858,102.358,104.095,106.597,109.594,113.59,117.586,120.088,123.589,125.326,129.826,132.823,134.56,137.062,141.562,145.558,147.295,153.298,159.796,164.8,167.05,168.787,173.791,176.293,180.289,183.79,190.792,194.788,198.784,203.284,205.786,210.286,212.788,217.288,219.025,223.525,227.521,232.021,236.521,239.518,242.02,244.522,247.024,251.02,252.757,256.753,260.749,263.251,265.753,269.254,270.991,273.988,278.992,285.49,291.493,294.994,297.991" svgx:width="0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.67,0.72,0.56,0.25,0.25,0.56,0.28,0.44,0.39,0.78,0.44,0.44,0.5,0.28,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.5,0.33,0.28,0.28,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.56,0.72,0.67,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">myelinated tracts of the CNS. Plasmacytoid dendritic cells (PDCs) </text>
   <text y="582.093" x="62.362,66.358,69.355,73.351,75.322,77.824,82.324,86.32,88.291,95.293,99.289,101.791,106.291,109.288,111.259,115.759,118.756,123.256,127.756,132.256,136.252,140.248,143.245,146.746,148.717,153.217,156.214,158.185,160.687,165.187,169.687,173.683,175.654,180.154,182.125,184.627,189.127,191.629,195.625,198.622,201.619,205.615,208.612,213.112,217.612,219.583,223.579,228.079,232.579,234.55,241.552,245.548,250.048,252.019,256.015,260.515,265.015,268.012,272.008,275.509,279.01,280.981,287.983,292.483,294.985" svgx:width="0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.28,0.5,0.33,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.5,0.44,0.25,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.33,0.44,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.25,0.78,0.5,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are the major producers of type 1 interferon and may express mol-</text>
   <text y="593.091" x="62.362,66.358,70.354,74.854,77.356,81.352,84.853,87.103,88.885,91.387,93.889,98.389,102.385,104.635,106.417,108.919,113.419,117.919,122.419,124.921,128.917,132.913,139.915,142.417,146.917,150.913,153.91,158.41,161.407,165.907,168.904,173.404,177.904,180.406,184.906,188.902,193.402,197.398,200.899,204.895,207.145,208.927,211.924,214.921,221.419,227.917,230.914,233.164,234.946,238.942,243.442,247.942,250.192,251.974,258.472,263.971,270.469,273.466,277.966,280.216,281.998,288.496,290.998,293.5,298.0" svgx:width="0.44,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.44,0.44,0.78,0.28,0.5,0.44,0.33,0.5,0.33,0.5,0.33,0.5,0.5,0.28,0.5,0.44,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.33,0.72,0.72,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.61,0.72,0.33,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ecules like indoleamine-2-3-oxigenase (IDO) and HLA-g with </text>
   <text y="604.089" x="62.362,64.864,71.866,78.868,83.368,87.868,92.368,95.869,100.369,104.869,109.369,112.366,116.362,119.863,123.364,125.866,130.366,134.362,136.243,140.239,143.074,146.071,150.067,154.063,156.565,158.815,160.201,166.699,170.2,172.081,180.082,185.086,186.967,189.469,192.97,194.851,198.847,200.728,205.228,207.73,211.231,215.227,219.223,222.724,226.72,228.601,235.099,237.601,240.103,244.603,246.484,248.986,253.486,256.483,258.985,262.981,269.983,276.985,280.981,283.483,285.985,290.485,294.985" svgx:width="0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.25,0.72,0.39,0.25,0.89,0.56,0.25,0.28,0.39,0.25,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immunosuppressive effect. As MS is a disease with inflammation-</text>
   <text y="615.087" x="62.362,65.359,69.355,71.857,75.853,78.355,82.351,86.851,89.677,93.178,97.678,104.68,109.18,111.682,116.182,123.184,126.685,128.935,131.761,135.757,138.259,140.761,143.587,150.589,154.585,159.085,161.587,165.583,168.085,172.585,176.581,180.082,182.908,185.905,190.405,193.402,196.228,204.229,209.233,212.059,216.055,218.557,225.559,228.385,235.387,239.887,244.387,248.887,251.389,255.385,257.887,260.389,264.889,269.389,272.215,276.715,279.712,282.538,286.039,290.539,295.039" svgx:width="0.33,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.25,0.44,0.28,0.28,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.39,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.25,0.44,0.28,0.78,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">related symptoms, all medicines for MS aim modulating or sup-</text>
   <text y="626.085" x="62.362,66.862,69.859,73.855,77.356,80.857,83.359,87.859,92.359,94.6,97.102,101.602,105.598,107.839,110.341,114.841,117.838,120.34,124.336,131.338,138.34,142.336,144.838,149.338,152.335,156.835,159.076,162.073,166.069,169.57,174.07,178.57,183.07,186.571,190.567,192.817,195.058,198.055,202.555,204.796,207.793,211.789,215.785,219.781,224.281,226.783,229.024,233.524,237.52,241.516,244.513,248.014,250.255,253.756,257.752,262.252,266.248,269.245,273.241,275.743,277.984,282.484,285.481,289.981,294.481,297.982" svgx:width="0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.25,0.33,0.5,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.33,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pressing the inflammatory response. In recent years several drugs </text>
   <text y="637.083" x="62.362,66.862,70.858,74.359,78.355,82.855,85.375,89.875,94.375,96.895,103.897,108.397,112.897,117.397,121.393,123.895,128.395,132.895,136.891,139.393,141.913,145.909,150.409,152.911,155.413,159.913,164.413,168.913,171.415,175.411,178.912,181.432,185.932,189.928,194.428,198.424,200.944,205.444,209.44,213.436,217.936,220.456,224.956,228.952,233.452,237.448,239.95,244.45,248.95,252.946,257.446,259.966,263.962,268.462,270.982,274.978,277.48,279.982,283.978,290.98,295.48,297.982" svgx:width="0.5,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.5,0.44,0.44,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.44,0.5,0.25,0.44,0.28,0.28,0.44,0.78,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">based on monoclonal antibodies have been developed an attempt </text>
   <text y="648.081" x="62.362,64.864,69.364,71.938,75.934,82.936,86.932,89.434,91.936,96.436,99.433,103.429,105.931,109.927,112.501,115.003,119.503,123.499,126.073,129.574,134.074,141.076,145.576,148.078,152.578,159.58,163.081,165.655,170.155,173.152,175.726,183.727,188.731,190.981,193.555,200.053,204.049,206.551,210.547,213.049,215.551,219.547,224.047,231.049,235.045,239.545,242.119,245.116,251.614,257.113,262.612,265.609,267.859,270.433,274.429,278.929,281.503,285.499,289.999,292.501,295.003" svgx:width="0.28,0.5,0.25,0.44,0.78,0.44,0.28,0.28,0.5,0.33,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.25,0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.33,0.72,0.61,0.61,0.33,0.25,0.25,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to ameliorate the symptoms of MS. Natalizumab (NTZ), an anti-</text>
   <text y="659.079" x="62.362,68.86,74.359,80.857,83.854,88.354,90.604,92.017,99.019,103.519,108.019,112.519,116.515,119.017,123.517,128.017,132.013,134.515,136.765,138.178,142.174,146.674,149.176,151.678,156.178,160.678,165.178,169.678,171.928,173.341,179.839,184.339,186.841,190.837,195.337,197.587,199.0,203.5,206.002,210.502,215.002,218.503,220.753,222.166,224.668,229.168,231.418,232.831,235.333,239.833,243.829,246.079,247.492,252.208,256.708,258.958,260.371,263.872,268.372,272.872,277.372,281.872,284.374,286.876,289.126,290.539,295.039,298.036" svgx:width="0.72,0.61,0.72,0.33,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.52,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.5,0.28,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">VLA-4 monoclonal antibody which binds to the α4 subunit of </text>
   <text y="670.077" x="62.362,67.078,71.578,76.159,80.659,83.449,87.445,91.945,96.445,99.235,103.951,108.451,113.032,117.532,120.322,122.824,127.324,129.826,133.822,138.322,141.319,143.821,148.321,151.822,154.612,158.608,163.108,167.608,170.605,174.601,178.102,181.603,185.599,190.099,192.889,197.389,201.889,204.679,207.181,211.681,215.677,218.467,221.968,226.468,229.465,232.462,236.458,240.454,244.45,247.24,251.74,254.737,257.527,261.523,265.519,268.021,270.523,275.023,279.019,281.521,285.517,290.017,292.645,297.982" svgx:width="0.52,0.5,0.51,0.5,0.25,0.44,0.5,0.5,0.25,0.52,0.5,0.51,0.5,0.25,0.28,0.5,0.28,0.44,0.5,0.33,0.28,0.5,0.39,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">α4β1 and α4β7 integrins expressed on the surface of activated T </text>
   <text y="681.075" x="62.362,66.358,70.354,72.856,75.358,78.859,81.109,83.98,87.976,92.476,96.976,99.478,103.978,107.479,110.35,112.852,117.352,121.348,124.219,131.221,133.723,138.223,141.22,145.216,147.718,150.22,154.72,159.22,162.091,166.087,170.083,173.08,177.58,181.081,184.582,187.453,189.955,194.455,198.451,201.322,205.822,208.324,212.824,217.324,221.824,224.821,229.321,232.318,236.314,238.816,243.316,246.187,250.687,254.683,257.68,260.677,263.179,267.175,270.172,273.043,275.545,280.045,286.543,290.539,293.536,298.036" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.28,0.5,0.39,0.25,0.28,0.5,0.44,0.25,0.78,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.44,0.33,0.5,0.39,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.33,0.5,0.33,0.44,0.28,0.5,0.25,0.5,0.44,0.33,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.72,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells, avoids the migration across the blood-brain barrier toward </text>
   <text y="692.073" x="62.362,64.864,69.364,71.614,74.566,77.068,81.568,85.564,87.814,90.766,96.769,103.267,108.271,110.521,113.473,117.973,122.473,124.723,127.675,131.671,136.171,140.671,145.171,147.673,152.173,156.169,158.671,161.173,165.169,167.671,169.921,172.873,175.87,179.866,183.862,187.858,192.358,194.86,199.36,202.357,205.858,208.108,211.06,214.561,219.061,223.057,227.557,229.807,232.759,236.755,240.256,242.506,245.296,251.794,257.797,264.295,272.296,275.293,279.793,282.043,284.995,288.991,293.491,297.991" svgx:width="0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.56,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.39,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.72,0.67,0.72,0.89,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to the CNS by endothelial receptors such as VCAM-1 and </text>
   <text y="703.071" x="62.362,65.359,71.362,77.86,85.861,88.858,93.358" svgx:width="0.33,0.67,0.72,0.89,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ICAM-1.</text>
   <text y="714.069" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="714.069" x="108.316,111.313,115.813,118.279,120.781,125.281,127.783,131.284,133.75,140.248,144.748,147.745,152.245,154.711,161.209,165.205,167.671,171.667,174.169,181.171,185.167,189.667,192.133,194.635,199.135,201.601,204.103,208.603,213.103,217.099,220.6,223.102,225.604,230.104,234.1,236.602,240.598,243.064,245.566,250.066,254.062,256.528,261.028,265.024,269.524,273.52,278.02,280.522,285.022,288.019,290.485,294.985,297.982" svgx:width="0.33,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.72,0.5,0.33,0.5,0.25,0.72,0.44,0.25,0.44,0.28,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.5,0.28,0.5,0.33,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In this work we aimed to investigate the behavior of </text>
   <text y="725.067" x="62.362,67.366,73.864,79.867,83.368,85.618,88.615,91.612,96.112,103.114,105.364,113.365,118.369,120.619,125.119,129.115,131.617,134.119,138.115,142.615,145.117,148.618,150.868,154.369,158.869,163.369,170.371,172.873,175.375,177.877,181.873,186.373,188.623,191.125,195.625,197.875,200.377,203.374,207.37,211.366,213.868,220.87,224.866,229.366,231.868,234.118,240.616,243.118,245.62,250.12,252.37,258.868,264.367,269.866" svgx:width="0.56,0.72,0.67,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.5,0.5,0.78,0.28,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PDCs from MS patients submitted to treatment with NTZ.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 314.300 L347.760 314.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="77.103" x="348.743,356.744,360.74,363.242,367.238,369.47,373.466,377.966,382.466,384.698,387.695,391.691,398.693,402.689,405.191,409.187,411.419,419.42,424.424,426.656,431.156,435.152,437.654,440.156,444.152,448.652,451.154,454.655,456.887,459.884,466.382,471.458,475.958,480.458,483.455,485.687,489.683,494.183,498.683,500.915,505.415,509.411,513.407,515.909,518.411,522.911,527.411,529.643,533.639,538.139,542.639" svgx:width="0.89,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.72,0.56,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Male and female MS patients (N=16) and healthy con-</text>
   <text y="88.101" x="310.016,312.518,315.515,320.015,322.517,326.018,328.268,329.06,333.56,337.556,340.058,346.556,350.552,354.548,359.048,361.298,362.09,366.59,371.09,373.34,374.132,378.128,382.628,387.128,389.378,390.17,394.67,399.17,401.42,402.212,406.712,410.708,414.704,417.701,421.202,423.452,424.244,428.744,431.246,435.746,437.996,438.788,445.286,449.282,452.279,456.275,458.525,459.317,463.817,468.317,471.314,473.564,474.356,478.856,481.853,486.353,490.853,495.353,497.603,498.395,502.895,505.892,508.142,508.934,512.435,514.937,519.437,523.937,527.852,530.102,532.352,533.144,538.148,542.648,545.645" svgx:width="0.28,0.33,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trols between 20 and 40 years old were our group of study. For </text>
   <text y="99.099" x="310.016,314.516,318.512,321.509,324.506,329.006,332.003,339.005,341.507,346.007,350.507,352.757,354.71,357.212,361.712,365.708,367.958,369.911,373.907,378.407,382.907,386.903,389.9,392.402,399.404,403.4,407.9,410.402,413.903,416.153,418.403,420.356,425.36,431.363,439.364,445.367,448.868,451.118,453.071,459.569,463.565,466.562,470.558,472.808,474.761,478.262,482.258,486.758,490.754,493.751,497.747,500.249,504.245,508.745,510.995,512.948,515.945,518.942,523.442,530.444,532.694,534.647,537.149,541.649,545.645" svgx:width="0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.44,0.33,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.56,0.67,0.89,0.67,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">performing the experiments, PBMCs were separated from the </text>
   <text y="110.097" x="310.016,314.516,317.018,321.518,326.018,330.518,333.083,337.079,341.579,346.079,348.644,352.145,356.645,363.647,367.643,370.208,374.204,378.2,381.197,385.193,389.693,392.69,397.19,400.691,405.191,407.693,412.193,416.189,418.691,421.256,424.253,426.755,431.255,433.757,438.257,440.822,447.32,451.316,454.817,457.382,461.378,465.878,468.38,470.882,474.878,478.874,481.376,485.372,489.872,492.122,494.192,500.69,505.19,507.692,510.194,513.191,519.194,525.692,531.695,538.193,541.19,545.69" svgx:width="0.5,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.78,0.44,0.25,0.44,0.44,0.33,0.44,0.5,0.33,0.5,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.33,0.67,0.72,0.67,0.72,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">blood and some cerebrospinal fluid was collected. Anti-BDCA-2 </text>
   <text y="121.095" x="310.016,314.012,318.512,323.012,325.784,329.78,334.28,336.782,339.284,342.281,348.779,354.278,360.776,363.773,368.273,371.045,375.041,379.541,382.043,384.545,389.045,393.545,398.045,400.547,404.543,408.044,410.816,413.813,419.816,426.314,429.086,435.089,437.591,442.091,445.592,449.588,452.09,456.086,460.586,464.582,468.578,472.079,475.076,477.848,484.346,488.342,491.339,495.335,498.107,502.607,506.108,510.104,514.604,517.376,519.878,524.378,527.15,534.152,538.148,541.145,545.645" svgx:width="0.44,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.72,0.61,0.72,0.33,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.33,0.67,0.72,0.25,0.67,0.28,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.78,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and anti-HLA-g antibodies (BD Biosciences) were used to mark </text>
   <text y="132.093" x="310.016,312.518,317.018,321.014,323.264,324.641,328.637,332.633,335.135,337.637,341.138,343.388,344.765,349.265,352.262,354.512,355.889,358.391,362.891,365.393,369.389,372.386,376.382,379.883,382.385,384.635,386.003,389.999,394.499,398.999,401.249,402.626,405.128,409.628,413.624,415.874,417.251,420.752,424.748,431.75,436.25,438.752,442.748,446.249,448.499,449.876,456.374,460.37,463.367,467.363,469.613,470.99,474.986,478.982,483.482,487.982,490.484,493.481,497.477,501.977,504.227,505.604,508.106,512.606,514.856,516.233,520.229,522.479,523.856,528.194,534.692,540.695,545.699" svgx:width="0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.44,0.39,0.28,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.44,0.5,0.5,0.28,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.56,0.72,0.67,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the cells of interest and the samples were acquired in a FACS </text>
   <text y="143.091" x="310.016,316.019,320.015,322.517,325.019,329.519,334.019,337.016,343.856,346.106,347.636,350.633,353.135,357.635,364.133,366.383,367.913,371.909,376.409,378.911,383.411,390.413,394.409,396.911,400.907,403.409,405.659,407.909,409.277,414.776,419.276,423.272,425.522,427.052,430.049,434.045,437.546,442.046,444.548,447.05,450.551,452.801,454.331,460.829,464.825,467.822,471.818,474.068,475.598,479.594,484.094,488.09,490.592,495.092,499.088,503.084,507.584,509.834,511.364,515.864,519.365,521.867,526.367,530.867,533.117,534.647,537.149,541.649,545.645" svgx:width="0.67,0.44,0.28,0.28,0.5,0.5,0.33,0.76,0.25,0.55,0.33,0.28,0.5,0.72,0.25,0.55,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.44,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Calibur® flow cytometer. The results were analyzed using the </text>
   <text y="154.089" x="310.016,313.517,318.017,321.014,323.516,330.014,334.01,337.007,341.003,343.253,343.937,350.435,354.431,356.933,361.433,365.429,369.425,371.675,373.925,374.609,382.61,386.606,391.106,395.606,398.603,407.099,411.599,414.101,416.603,421.103,425.099,429.599,431.849,432.533,435.035,439.031,442.532,445.034,447.284,447.968,454.466,458.462,461.963,464.213,464.897,469.397,472.898,476.894,481.394,483.644,484.328,487.325,491.825,494.822,497.072,497.756,500.258,504.758,508.754,511.004,511.688,515.189,517.691,521.687,524.189,526.691,530.192,532.694,535.196,539.192,543.188,545.69" svgx:width="0.39,0.5,0.33,0.28,0.72,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.28,0.5,0.44,0.44,0.25,0.25,0.55,0.89,0.44,0.5,0.5,0.33,0.94,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.44,0.28,0.28,0.39,0.28,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">software Kaluza. Mann-Whitney test was used for the statistical </text>
   <text y="165.087" x="310.016,314.012,318.512,322.508,325.01,329.51,333.011,337.007,340.508,342.758,346.754,351.254,355.754,358.004,362.504,365.501,370.001,373.997,376.499,380.999,384.995,387.245,392.321,394.571,399.071,401.321,405.821,408.071,414.569,418.565,422.066,424.316,428.312,432.812,437.312,440.813,443.315,447.815,451.811,454.808,458.804,463.304,465.554,469.055,471.557,476.057,480.557,483.059,486.056,488.558,492.554,496.55,501.05,503.552" svgx:width="0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.44,0.28,0.5,0.44,0.25,0.56,0.25,0.5,0.25,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.39,0.28,0.5,0.44,0.33,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">analyses and p-value &lt; 0.5 was considered significant.</text>
   <text y="176.085" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="176.085" x="345.395,348.392,352.892,355.142,357.275,361.775,365.771,368.273,370.775,374.771,379.271,381.773,385.274,387.524,389.657,396.155,398.657,401.159,405.659,407.909,410.042,413.039,417.035,419.537,423.533,428.033,431.534,434.036,438.536,443.036,446.033,449.03,453.026,460.028,462.53,465.032,467.534,470.036,474.536,479.036,481.286,483.419,491.42,496.424,498.674,500.807,503.309,506.306,510.302,514.298,516.8,520.796,525.296,527.546,529.679,536.177,538.679,541.181,545.681" svgx:width="0.33,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In patients with relapsing-remitting MS treated with </text>
   <text y="187.083" x="310.016,316.514,322.013,327.512,329.762,332.039,338.537,342.533,344.81,349.31,353.81,357.311,361.307,364.304,368.804,372.8,377.3,379.577,383.573,385.85,389.351,391.853,396.353,400.853,403.355,406.352,408.854,412.85,416.846,421.346,423.848,426.125,428.627,433.127,437.123,440.12,444.116,448.112,451.613,455.609,457.886,462.386,465.383,467.66,474.158,479.657,486.155,489.152,493.652,495.929,499.925,504.425,508.925,511.922,515.918,519.419,522.92,525.422,529.922,534.422,536.699,541.199,545.699" svgx:width="0.72,0.61,0.61,0.25,0.25,0.72,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.72,0.61,0.72,0.33,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NTZ, we observed a significant increase of HLA-g expressing on </text>
   <text y="198.081" x="310.016,315.02,321.518,327.521,331.022,333.272,334.145,337.142,340.139,344.639,351.641,353.891,354.764,357.266,361.766,365.762,368.012,368.885,373.385,377.381,380.378,382.88,387.38,391.88,395.876,398.873,402.869,405.371,407.621,408.494,412.994,415.496,419.996,424.496,428.996,431.246,432.119,436.115,440.615,445.115,447.365,448.238,450.74,455.24,459.236,461.486,462.359,466.859,469.856,473.852,477.353,481.349,485.849,489.845,493.841,496.091,496.964,501.464,504.461,506.711,507.584,514.082,519.581,526.079,529.076,535.574,537.824,538.697,541.199,545.699" svgx:width="0.56,0.72,0.67,0.39,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.61,0.72,0.33,0.72,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PDCs from the peripheral blood and the presence of HLA-G in </text>
   <text y="209.079" x="310.016,315.02,321.518,327.521,331.022,333.272,335.774,340.274,342.524,346.52,350.516,353.513,357.509,362.009,365.006,369.506,373.007,377.507,380.009,384.509,388.505,391.007,393.257,396.254,398.756,403.256,405.758,410.258" svgx:width="0.56,0.72,0.67,0.39,0.25,0.28,0.5,0.25,0.44,0.44,0.33,0.44,0.5,0.33,0.5,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PDCs in cerebrospinal fluid.</text>
   <text y="220.077" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="220.077" x="361.982,368.48,372.98,375.977,378.434,381.431,385.427,388.928,393.428,395.93,398.432,401.933,404.39,407.891,412.391,416.891,421.391,425.387,428.888,431.39,433.847,436.349,440.849,444.845,447.347,449.804,452.306,456.806,459.263,463.259,467.759,472.259,474.761,477.263,479.765,484.265,488.765,491.222,493.724,498.224,500.681,505.181,507.683,512.183,516.179,520.679,523.181,527.681,532.181,534.638,537.14,541.64,545.636" svgx:width="0.72,0.5,0.33,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our results suggest that in addition to blocking the </text>
   <text y="231.075" x="310.016,317.018,319.52,324.02,327.017,331.013,333.515,336.017,340.517,345.017,346.943,351.443,354.44,356.366,360.362,364.358,366.86,369.362,373.862,377.858,380.36,384.356,388.856,390.62,395.957,397.883,401.879,405.875,408.377,410.879,414.38,416.63,418.556,425.054,430.553,436.052,437.978,444.98,448.976,453.476,455.402,459.398,463.898,468.398,470.9,473.897,476.399,480.899,485.399,487.901,491.897,493.823,496.325,500.825,502.751,505.253,509.753,513.749,515.675,522.677,527.177,531.677,536.177,538.679,542.675" svgx:width="0.78,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.72,0.61,0.61,0.25,0.78,0.44,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">migration of activated T cells, NTZ may contribute to the modula-</text>
   <text y="242.073" x="310.016,312.518,315.02,319.52,324.02,326.27,330.77,333.767,336.017,338.519,343.019,347.015,349.265,351.767,356.267,359.264,361.766,365.762,372.764,379.766,383.762,386.264,390.764,393.761,398.261,400.511,403.508,407.504,411.005,415.505,420.005,424.505,428.006,432.002,434.252,436.754,441.254,443.504,448.004,452.0,454.502,457.004,461.0,465.5,468.002,471.503,473.753,480.251,482.753,485.255,489.755,492.005,500.006,505.01" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of the inflammatory response in patients with MS.</text>
   <text y="269.073" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P976</text>
   <text y="280.071" x="310.016,316.019,319.016,322.013,326.009,330.005,333.002,336.503,338.753,343.253,346.25,348.5,353.0,355.502,359.498,366.995,369.992,374.996,378.992,383.996,391.493,395.993,400.997,403.247,407.747,412.751,415.001,418.502,422.498,425.0,428.996,432.992,435.989,438.491,442.991,446.987,449.237,451.739,459.236,466.733,471.737,476.741,480.737,482.987,486.983,490.979,493.481,495.983,498.233,501.734,506.738,511.742,515.243,519.239,522.236,525.737" svgx:width="0.67,0.33,0.33,0.44,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.44,0.83,0.33,0.56,0.44,0.56,0.83,0.5,0.56,0.25,0.5,0.56,0.25,0.39,0.44,0.28,0.44,0.44,0.33,0.28,0.5,0.44,0.25,0.28,0.83,0.83,0.56,0.56,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.56,0.56,0.39,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Effects of alemtuzumab on selective immune cell subsets </text>
   <text y="291.069" x="310.016,312.518,317.522,319.772,322.769,327.773,331.769,334.019,339.023,341.525,346.025,350.525,355.529,357.779,362.279,365.276,367.526,372.53,377.03,380.027,382.529,386.525,391.529,394.526,398.027,400.277,406.775,409.277,412.274,417.278,419.528,423.524,427.52,430.022,434.522,439.526,443.027,445.529,450.533,455.033,457.283,461.279,465.275,472.772,475.274,478.271,481.268,483.77,488.774,493.274,495.524,503.021,508.025,510.527,513.524,516.026,521.03,523.532,527.528" svgx:width="0.28,0.56,0.25,0.33,0.56,0.44,0.25,0.56,0.28,0.5,0.5,0.56,0.25,0.5,0.33,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.72,0.28,0.33,0.56,0.25,0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.25,0.44,0.44,0.83,0.28,0.33,0.33,0.28,0.56,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">in the blood of patients with relapsing remitting multiple </text>
   <text y="302.067" x="310.016,313.517,317.513,320.015,324.011,328.007,332.507,336.008,338.51" svgx:width="0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">sclerosis</text>
   <text y="313.065" x="310.016,316.514,318.764,324.263,328.763,333.263,340.265,344.261" svgx:width="0.72,0.25,0.61,0.5,0.5,0.78,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">K Thomas</text>
   <text y="310.583" x="347.761" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="350.686,352.936,355.186,358.687,360.937,366.94,369.442,373.438,377.938,382.438,386.434,390.934,395.434,398.431" svgx:width="0.25,0.25,0.39,0.25,0.67,0.28,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Blankeburg</text>
   <text y="310.583" x="402.931" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="405.856,408.106,410.356,413.857,416.107,421.606,424.108,427.609,431.605,434.107" svgx:width="0.25,0.25,0.39,0.25,0.61,0.28,0.39,0.44,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Eisele</text>
   <text y="310.583" x="438.102" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="313.103" x="441.027,443.277,445.527,451.026,453.276,458.775,461.277,465.273,472.275,475.776,479.277,483.273" svgx:width="0.25,0.25,0.61,0.25,0.61,0.28,0.44,0.78,0.39,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Ziemssen</text>
   <text y="310.583" x="487.773" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="321.581" x="310.015" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="324.103" x="312.941,319.439,323.939,326.441,330.437,334.433,337.934,341.435,343.937,346.439,350.435,352.685,359.183,363.683,367.184,371.684,374.186,376.688,381.188,383.69,385.94,392.438,395.939,399.935,403.436,407.936,411.932,416.432,418.682,420.932,426.935,430.931,435.431,437.933,441.929,445.43,447.68,452.18,454.682,456.932,462.935,465.437,467.939,472.439,474.941,478.937,483.437,485.939,488.189,494.192,498.188,502.688,506.189,510.689,514.19,518.186,520.688,524.684,529.184,533.18,537.176,539.426" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital Dresden, Center of Clinical Neuroscience, </text>
   <text y="335.101" x="310.016,316.514,320.015,324.011,327.512,332.012,336.008,340.508,342.758,345.008,351.506,355.502,359.003,365.501,370.001,374.501" svgx:width="0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dresden, Germany</text>
   <text y="362.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="362.101" x="362.531,368.03,372.53,376.526,378.695,385.697,390.197,394.697,399.197,403.193,405.695,410.195,414.695,418.691,421.193,423.353,427.349,431.849,434.351,436.853,439.85,445.853,452.351,456.851,461.351,463.52,467.516,472.016,474.518,477.02,481.52,486.02,490.52,495.02,497.18,501.176,503.678,507.674,514.676,517.178,521.678,525.674,530.174,537.176,541.172,545.672" svgx:width="0.61,0.5,0.44,0.25,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.28,0.28,0.33,0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The monoclonal anti-CD52 antibody alemtuzumab </text>
   <text y="373.099" x="310.016,317.018,321.014,325.514,328.016,332.012,334.514,338.51,342.011,344.261,345.143,349.139,353.639,356.141,358.643,363.143,367.643,372.143,376.643,378.893,379.775,383.771,388.271,392.771,395.021,395.903,399.899,404.399,411.401,415.901,418.403,422.399,429.401,433.397,437.897,440.399,443.396,447.896,451.892,456.392,460.388,464.888,469.388,471.89,476.39,480.89,483.14,484.022,488.018,492.518,495.02,499.52,502.022,506.522,511.022,513.524,517.52,520.022,522.524,526.439,528.689,530.939,531.659,537.158,541.658,545.654" svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.78,0.44,0.5,0.28,0.33,0.5,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mediates antibody and complement-depending cytotoxicity. The </text>
   <text y="384.097" x="310.016,314.012,318.512,323.012,325.514,328.016,332.012,336.008,338.51,341.012,345.512,350.012,352.262,353.405,357.905,360.902,363.152,364.295,368.291,370.793,374.789,381.791,384.293,388.793,392.789,397.289,404.291,408.287,412.787,415.037,416.18,419.177,423.173,426.674,431.174,433.676,436.178,439.679,441.929,443.072,445.574,450.074,452.324,453.467,457.463,461.963,464.213,465.356,469.352,471.854,474.356,478.352,481.349,485.345,489.845,492.095,493.238,497.738,500.24,503.741,506.243,509.24,511.742,516.242,520.742,523.244,525.746,530.246,534.746,536.996,538.139,542.639,545.636" svgx:width="0.44,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">application of alemtuzumab results in an altered distribution of </text>
   <text y="395.095" x="310.016,314.516,317.018,319.853,322.85,326.846,329.843,333.839,338.339,340.841,343.181,345.683,352.685,359.687,364.187,368.687,372.683,375.023,379.019,383.015,385.517,388.019,390.359,393.86,398.36,402.86,405.362,409.862,414.362,418.358,421.859,424.109,426.449,431.948,434.45,436.952,439.454,441.956,445.952,448.292,450.794,454.295,456.635,461.135,465.635,470.135,476.633,481.133,483.473,487.469,491.969,496.469,500.969,503.471,505.811,510.311,512.813,515.648,518.645,522.641,525.638,529.634,534.134,536.636,539.138,543.134,545.636" svgx:width="0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.25,0.61,0.28,0.28,0.28,0.28,0.44,0.25,0.28,0.39,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">different immune cell subtypes. Little is known about differential </text>
   <text y="406.093" x="310.016,316.019,322.517,327.017,331.517,334.514,338.51,343.01,347.51,350.507,354.503,358.004,361.505,364.007,368.507,373.007,375.608,379.604,384.104,388.604,391.205,394.706,399.206,403.202,407.198,409.7,412.697,415.199,419.195,421.796,426.296,430.292,434.792,437.294,441.29,443.792,446.294,450.794,455.294,457.895,461.891,466.391,470.891,473.492,476.489,480.485,484.481,488.981,493.481,497.477,500.474,504.974,507.575,512.075,515.072,517.673,522.173,526.169,529.166,531.668,534.17,538.166,542.666" svgx:width="0.67,0.72,0.5,0.5,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD52-expression and specific depletion and recovery of particu-</text>
   <text y="417.091" x="310.016,312.518,316.514,319.511,321.761,325.757,329.753,332.255,334.757,337.007,340.508,345.008,349.508,352.01,356.51,361.01,365.006,368.507" svgx:width="0.28,0.44,0.33,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lar cell subtypes.</text>
   <text y="428.089" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="428.089" x="358.238,363.107,367.607,369.857,372.35,376.346,380.846,384.842,387.344,391.844,395.84,398.342,402.338,404.588,407.072,411.068,413.903,416.9,420.896,424.892,427.394,430.895,433.145,435.629,440.129,443.126,445.376,447.869,451.865,454.367,458.363,465.365,467.867,472.367,476.363,480.863,487.865,491.861,496.361,498.611,501.095,505.595,510.095,512.345,514.838,519.338,521.84,524.675,527.672,531.668,534.665,538.661,543.161,545.663" svgx:width="0.61,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate effects of alemtuzumab on different </text>
   <text y="439.087" x="310.016,312.518,319.52,326.522,331.022,335.522,339.518,341.768,345.764,349.76,352.262,354.764,357.014,360.515,365.015,369.515,372.017,376.517,381.017,385.013,388.514,390.764,393.266,397.766,400.016,407.018,411.518,414.02,416.522,419.024,423.524,426.026,430.022,432.272,435.773,439.769,442.271,446.267,449.264,453.764,457.265,459.767,463.268,465.518,470.018,474.014,476.516,479.018,483.014,487.514,490.016,493.517" svgx:width="0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immune cell subtypes in multiple sclerosis patients.</text>
   <text y="450.085" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="450.085" x="348.752,353.756,357.752,360.749,363.251,367.751,372.251,376.247,379.244,383.24,385.742,387.983,392.483,394.985,399.485,403.985,408.485,410.726,417.728,422.228,426.728,431.228,435.728,440.228,444.224,446.726,450.722,454.718,457.715,459.956,463.952,467.948,470.45,472.952,476.453,478.694,481.691,484.688,489.188,496.19,498.431,502.931,507.431,509.672,512.669,516.665,519.167,523.163,527.663,531.164,533.666,538.166,542.666" svgx:width="0.56,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.78,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Peripheral blood mononuclear cells from 12 relapsing-</text>
   <text y="461.083" x="310.016,313.013,317.009,324.011,326.513,329.015,331.517,334.019,338.519,343.019,345.665,352.667,357.167,359.669,362.171,364.673,369.173,371.675,375.671,378.317,381.818,385.814,388.316,392.312,395.309,399.809,403.31,405.812,409.313,411.959,416.459,420.455,422.957,425.459,429.455,433.955,436.457,439.958,442.604,449.102,453.098,456.095,460.091,462.737,467.237,470.234,474.23,480.728,485.228,487.874,492.374,496.37,499.367,503.867,506.864,510.86,513.506,517.502,522.002,526.502,529.148,533.144,536.141,538.643,542.639,545.636" svgx:width="0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.33,0.44,0.72,0.5,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remitting multiple sclerosis patients were drawn before and after </text>
   <text y="472.081" x="310.016,314.012,316.514,320.51,327.512,330.014,334.514,338.51,343.01,350.012,354.008,358.508,360.839,363.341,367.841,370.838,375.338,378.839,381.341,385.841,390.341,392.672,395.174,399.674,403.67,406.172,410.672,415.172,417.674,422.174,426.674,429.005,433.505,437.501,441.002,444.998,447.5,450.002,454.502,458.498,460.748,463.079,470.081,474.581,479.081,481.583,486.083,488.414,491.411,499.412,502.409,504.74,509.24,511.49,513.821,521.822,526.322,528.572,530.903,538.904,543.404,545.654" svgx:width="0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.33,0.89,0.33,0.25,0.5,0.25,0.25,0.89,0.5,0.25,0.25,0.89,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alemtuzumab infusion including baseline, month (M) 3, M6, M9, </text>
   <text y="483.079" x="310.016,318.017,322.517,327.017,329.267,331.841,339.842,344.342,348.842,351.092,353.666,361.667,366.167,370.667,372.917,375.491,383.492,387.992,392.492,395.066,399.062,403.562,408.062,410.636,418.637,423.137,427.637,429.887,432.461,437.465,441.965,444.962,447.959,451.955,455.951,459.947,462.521,466.517,471.017,475.517,478.091,480.593,485.093,487.595,490.592,494.588,498.584,502.58,505.082,507.584,512.084,514.586,518.582,521.579,524.153,531.155,535.151,538.148,542.648" svgx:width="0.89,0.5,0.5,0.25,0.25,0.89,0.5,0.5,0.25,0.25,0.89,0.5,0.5,0.25,0.25,0.89,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.89,0.5,0.5,0.25,0.25,0.56,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.28,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25,0.78,0.44,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M12, M15, M18, M21 and M24. Surface and intracellular mark-</text>
   <text y="494.077" x="310.016,314.012,317.009,320.51,322.886,327.386,330.383,332.597,337.268,340.265,344.261,348.257,350.759,353.261,355.511,357.887,363.89,366.887,370.883,374.879,377.381,379.883,382.133,384.509,391.007,397.505,400.502,404.498,408.494,410.996,413.498,415.874,419.87,424.37,428.87,430.751,437.249,442.253,448.256,450.632,454.133,458.633,463.133,467.633,472.133,476.633,481.133,483.635,487.631,490.133,492.635,497.135,501.635,505.136,507.512,514.01,518.006,521.003,524.999,527.375,531.371,535.871,539.867,542.675" svgx:width="0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.25,0.25,0.72,0.72,0.33,0.44,0.44,0.28,0.28,0.25,0.44,0.5,0.5,0.25,0.72,0.56,0.67,0.25,0.39,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ers of T-cell, B-cell, NK-cell and APC subpopulations were char-</text>
   <text y="505.075" x="310.016,314.012,318.008,320.51,324.506,327.503,330.005,334.001,337.997,342.497,344.747,345.701,352.199,354.701,357.203,361.703,363.953,364.907,367.904,370.406,374.906,379.406,382.403,386.399,389.9,393.896,397.892,402.392,406.388,410.384,413.381,415.883,419.879,424.379,428.375,430.877,434.873,439.373,441.623,442.577,446.573,451.073,453.575,456.077,460.577,465.077,469.577,472.079,476.075,479.576,481.826,482.78,486.776,491.276,495.776,498.026,498.98,502.976,507.476,511.472,513.974,518.474,522.47,524.972,528.968,533.468,535.718,536.672,541.172,545.672" svgx:width="0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.28,0.5,0.5,0.33,0.44,0.39,0.44,0.44,0.5,0.44,0.44,0.33,0.28,0.44,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">acterized with fluorescence-labeled antibodies and evaluated on </text>
   <text y="516.073" x="310.016,315.515,320.519,326.522,329.519,334.523,339.023,342.02,344.522,348.518,352.019,355.52,359.516" svgx:width="0.61,0.56,0.67,0.33,0.56,0.5,0.33,0.28,0.44,0.39,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LSR-Fortessa.</text>
   <text y="527.071" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="527.071" x="343.775,349.778,353.774,358.274,362.27,365.267,369.767,372.269,376.769,381.269,384.032,390.035,396.533,401.033,405.533,408.296,412.292,416.792,421.292,424.289,428.285,431.786,435.287,437.789,442.289,446.789,449.039,451.802,457.805,464.303,468.803,473.879,476.642,480.638,485.138,489.638,492.239,497.423,500.42,504.416,508.916,511.913,515.909,519.905,522.407,524.909,528.41,531.173,535.673,538.67,542.666" svgx:width="0.67,0.44,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.67,0.72,0.5,0.5,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.25,0.67,0.72,0.5,0.56,0.25,0.44,0.5,0.5,0.25,0.61,0.33,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Regarding CD52 expression, CD8+ and Treg-cells pre-</text>
   <text y="538.069" x="310.016,313.517,317.513,322.013,324.515,328.511,333.011,335.261,337.331,339.833,344.333,350.831,354.827,357.824,360.074,362.153,368.156,374.654,379.154,383.654,386.651,391.151,395.147,398.648,402.644,405.146,407.648,412.148,416.144,418.394,420.464,424.46,428.96,433.46,436.457,440.453,443.954,447.455,449.957,454.457,458.957,461.207,463.286,465.788,470.288,474.284,478.784,481.034,483.104,489.107,495.605,500.105,505.181,507.431,509.501,513.497,517.997,522.497,524.747,526.664,532.163,536.663,541.163,545.663" svgx:width="0.39,0.44,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.67,0.72,0.5,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sented lower CD52-baseline expression than CD4+ and Th17 </text>
   <text y="549.067" x="310.016,314.687,317.684,321.68,325.676,328.178,330.68,334.181,336.431,338.681,342.029,348.032,354.53,359.03,363.53,366.527,371.027,375.023,378.524,382.52,385.022,387.524,392.024,396.02,398.27,401.618,405.614,410.114,414.614,417.611,421.607,425.108,428.609,431.111,435.611,440.111,442.361,445.709,450.209,452.711,457.211,459.461,462.809,467.309,471.809,474.311,476.561,479.909,484.409,486.911,489.746,492.743,496.739,499.736,501.986,505.334,507.836,512.336,514.586,517.934,523.937,526.934,530.93,534.926,537.428,539.93,543.431,545.681" svgx:width="0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.67,0.72,0.5,0.5,0.33,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T-cells. CD52-baseline expression did not differ in B-cells. </text>
   <text y="560.065" x="310.016,316.019,320.015,323.516,327.512,330.014,332.516,337.016,341.012,343.262,346.205,352.208,358.706,363.206,367.706,370.703,374.699,379.199,383.699,386.696,390.692,394.193,397.694,400.196,404.696,409.196,411.446,414.389,418.889,421.391,424.892,429.392,431.894,435.89,440.39,444.386,448.886,451.136,454.079,456.581,461.081,467.579,471.575,475.076,477.578,479.828,482.771,486.767,493.769,498.269,502.769,507.269,509.771,513.272,515.522,518.465,522.965,527.465,529.715,532.658,539.156,545.654" svgx:width="0.67,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.5,0.5,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.5,0.28,0.44,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.72,0.44,0.39,0.28,0.25,0.55,0.44,0.78,0.5,0.5,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Baseline CD52-expression displayed lowest amounts on NK </text>
   <text y="571.063" x="310.016,314.012,318.008,320.51,323.012,326.513,328.763,331.157,335.153,339.653,346.655,351.155,355.151,358.148,362.144,366.644,369.038,371.54,376.04,378.434,382.934,385.436,389.936,393.932,396.929,399.323,403.319,407.315,409.817,412.319,414.713,418.214,422.714,427.214,430.715,434.711,437.213,440.714,442.964,445.358,451.361,457.859,462.359,466.859,469.856,473.852,478.352,482.852,485.849,489.845,493.346,496.847,499.349,503.849,508.349,510.743,517.241,521.237,524.738,527.132,530.633,533.135,540.137,542.639" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.25,0.67,0.72,0.5,0.5,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.78,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells, compared to other cell subsets. CD52-expression was simi-</text>
   <text y="582.061" x="310.016,312.518,316.514,319.511,321.761,324.263,328.763,335.261,337.511,342.011,346.007,348.509,355.007,359.003,362.999,367.499,369.749,373.745,376.247,378.749,380.999,383.501,388.001,392.501,396.497,399.998,402.5,405.002,409.502,413.498,416.0,419.996,424.496,426.251,432.749,437.753,443.756,446.006,449.507,454.007,458.507,461.009,465.509,470.009,474.005,477.506" svgx:width="0.28,0.44,0.33,0.25,0.28,0.5,0.72,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.44,0.28,0.28,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.72,0.56,0.67,0.25,0.39,0.5,0.5,0.28,0.5,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lar low between all investigated APC subtypes.</text>
   <text y="593.059" x="322.013,328.511,333.011,336.512,341.012,343.514,348.014,350.516,354.512,356.951,361.451,365.951,372.953,377.453,381.449,384.446,387.947,390.386,394.886,397.883,400.322,406.325,412.823,417.323,422.399,424.838,428.834,433.334,437.834,440.273,446.276,452.774,457.274,462.35,464.627,469.298,472.295,476.291,480.287,482.789,485.291,488.792,491.231,495.731,499.727,503.723,506.72,510.716,514.712,518.213,522.209,526.709,529.148,533.144,536.141,538.643,542.639,545.636" svgx:width="0.72,0.5,0.39,0.5,0.28,0.5,0.28,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.56,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Absolute numbers of CD4+ and CD8+ T-cells decreased after </text>
   <text y="604.057" x="310.016,314.012,316.514,320.51,327.512,330.014,334.514,338.51,343.01,350.012,354.008,358.508,360.758,362.234,366.734,370.73,373.727,377.228,379.73,383.231,385.733,388.235,392.735,397.235,399.485,400.961,405.461,409.961,412.211,413.687,416.189,420.689,422.939,424.415,432.416,436.916,441.416,443.666,445.916,447.392,453.395,457.391,459.893,463.889,466.391,468.893,473.393,477.389,479.639,481.115,485.615,490.115,497.117,501.617,505.613,508.61,510.86,512.336,516.836,519.833,522.083,523.559,529.562,536.06,540.56,545.636" svgx:width="0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.39,0.28,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.5,0.5,0.25,0.25,0.55,0.67,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alemtuzumab persisting up to M24. Relative number of CD4+ </text>
   <text y="615.055" x="310.016,312.518,317.018,324.02,328.52,333.02,337.52,341.516,346.016,348.518,352.514,356.015,358.265,361.19,364.187,368.183,375.185,379.181,381.683,386.183,390.179,394.679,396.929,399.854,404.354,408.35,412.85,415.352,419.348,421.85,425.846,430.346,432.596,434.846,437.771,444.269,448.769,452.765,455.762,459.758,463.754,467.255,469.505,472.43,478.433,484.931,489.431,494.507,496.757,499.682,502.184,506.684,513.686,518.186,522.686,527.186,531.182,535.682,538.184,542.18,545.681" svgx:width="0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.55,0.67,0.72,0.5,0.56,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymphocytes remained depleted, whereas CD8+ lymphocytes </text>
   <text y="626.053" x="310.016,313.013,317.009,321.005,325.001,329.501,333.497,337.997,339.545,344.045,348.041,351.542,355.538,358.04,360.542,365.042,369.038,370.586,375.086,379.082,381.584,386.084,390.08,393.581,395.129,399.125,401.627,403.175,411.176,415.676,417.926,419.474,422.471,426.971,428.519,436.52,441.02,443.27,444.818,450.821,457.319,461.819,466.895,468.443,472.439,476.939,481.439,482.987,488.99,495.488,499.988,505.064,506.612,512.615,519.113,523.613,528.113,534.116,540.614,545.69" svgx:width="0.33,0.44,0.44,0.44,0.5,0.44,0.5,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.44,0.28,0.25,0.89,0.5,0.25,0.25,0.33,0.5,0.25,0.89,0.5,0.25,0.25,0.67,0.72,0.5,0.56,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.67,0.72,0.5,0.5,0.67,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reached baseline values at M6. In M3, CD4+ and CD8+ CD45RA+ </text>
   <text y="637.051" x="310.016,314.012,318.008,320.51,323.012,326.513,328.763,330.221,334.721,338.717,342.713,345.71,349.706,353.702,357.203,361.199,365.699,367.949,369.407,373.403,377.903,382.403,384.653,386.111,389.108,393.104,395.606,400.106,403.103,407.603,411.599,416.099,418.349,419.807,422.309,426.809,429.059,430.517,435.017,439.013,442.514,446.51,449.012,451.514,456.014,460.01,462.26,463.718,467.714,470.711,473.213,477.209,480.206,482.456,483.914,491.915,496.415,500.915,503.165,505.415,506.873,512.876,519.374,523.874,528.95,531.2,532.658,536.654,541.154,545.654" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.5,0.33,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.89,0.5,0.5,0.25,0.25,0.55,0.67,0.72,0.5,0.56,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells decreased and returned to baseline after M12. CD4+ and </text>
   <text y="648.049" x="310.016,316.019,322.517,327.017,332.093,334.343,341.399,347.402,353.9,358.4,362.9,368.903,375.401,380.477,384.473,388.469,390.971,393.473,396.974,399.224,406.28,410.78,413.777,418.277,422.273,426.269,430.265,434.765,438.761,443.261,445.511,452.567,455.069,459.569,461.819,468.875,471.377,475.877,479.873,482.123,489.179,493.679,498.179,502.679,507.179,510.68,513.182,515.684,519.68,521.93,528.986,535.484,539.48,543.395,545.645" svgx:width="0.67,0.72,0.5,0.56,0.25,0.55,0.67,0.72,0.5,0.5,0.67,0.72,0.56,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.44,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25,0.55,0.72,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD8+ CD45RO+cells proceeded in the opposite way. </text>
   <text y="659.047" x="310.016,316.019,322.517,327.017,332.093,338.096,344.594,349.094,353.594,358.67,363.674,368.174,372.674,377.678,382.178,387.254,389.504,391.061,396.245,399.242,403.238,407.738,410.735,414.731,418.727,421.229,423.731,427.232,429.482,431.201,433.703,438.203,442.199,445.196,449.192,453.188,456.689,460.685,465.185,467.435,469.154,471.656,476.156,478.406,480.125,488.126,492.626,494.876,497.126,498.683,504.182,508.682,513.182,517.682,519.932,521.489,526.16,529.157,533.153,537.149,539.651,542.153,545.654" svgx:width="0.67,0.72,0.5,0.56,0.67,0.72,0.5,0.5,0.56,0.56,0.5,0.5,0.56,0.5,0.56,0.25,0.55,0.61,0.33,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.5,0.25,0.25,0.55,0.61,0.5,0.5,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD4+CD25+FoxP3+ Treg-cells increased in M3. Th17 T-cells </text>
   <text y="670.045" x="310.016,314.516,318.512,322.508,325.505,329.501,333.497,336.998,340.994,345.494,347.744,355.169,359.669,363.665,366.662,370.163,372.665,376.166,378.668,382.664,387.164,389.666,392.168,396.668,398.918,406.343,410.339,413.336,415.838,419.834,422.831,425.081,432.506,436.502,439.004,443.0,450.002,452.504,457.004,461.0,465.5,472.502,476.498,480.998,483.248,485.498,487.748,494.678,501.176,503.678,507.674,514.676,517.178,521.678,525.674,530.174,537.176,541.172,545.672" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.44,0.33,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.25,0.55,0.72,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased persistently after alemtuzumab.. Alemtuzumab </text>
   <text y="681.043" x="310.016,314.516,318.512,322.508,325.505,329.501,333.497,336.998,340.994,345.494,347.744,349.013,351.515,356.015,360.011,362.261,363.53,368.03,372.53,379.532,384.032,388.028,391.025,393.275,394.544,399.044,402.041,404.291,405.56,411.563,418.061,422.561,427.061,432.137,434.387,435.656,441.659,444.656,448.652,452.648,455.15,457.652,461.153,463.403,464.672,471.17,475.67,478.172,482.168,486.668,488.918,490.187,493.184,497.18,501.176,505.676,510.176,514.172,517.169,521.165,525.665,527.915,529.184,533.684,538.184,540.686,543.188,545.69" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.28,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased the number of CD19+ B-cells which recovered until </text>
   <text y="692.041" x="310.016,318.017,322.517,327.017,329.267,331.517,332.39,335.387,339.887,344.387,346.889,351.389,353.891,358.391,362.891,366.887,369.389,371.639,372.512,378.515,381.512,385.508,389.504,392.006,394.508,396.758,397.631,401.132,405.632,410.132,413.633,417.629,420.131,423.632,425.882,426.755,429.257,433.757,437.753,440.255,444.755,449.255,451.757,456.257,460.757,463.007,463.88,469.883,476.381,480.881,485.381,490.457,496.46,502.958,507.458,511.958,517.034,519.284,520.157,526.16,529.157,533.153,537.149,539.651,542.153,545.654" svgx:width="0.89,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.67,0.72,0.5,0.5,0.56,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M12. Individual B-cell subsets including CD19+CD27+ B-cells </text>
   <text y="703.039" x="310.016,313.517,318.017,322.517,329.015,333.011,337.511,339.761,342.974,346.97,349.22,352.433,356.933,360.929,363.926,367.427,369.929,373.43,375.932,379.928,384.428,386.93,389.18,392.393,396.893,400.889,404.885,407.882,411.878,415.874,419.375,423.371,425.621,427.871,431.084,437.582,442.082,446.078,449.075,453.071,457.067,460.568,462.818,466.031,472.034,478.532,483.032,487.532,492.608,498.611,505.109,509.609,514.685,516.935,520.148,526.151,529.148,533.144,537.14,539.642,542.144,545.645" svgx:width="0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.33,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.25,0.55,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.55,0.67,0.72,0.5,0.5,0.56,0.67,0.72,0.5,0.56,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">showed a persistent decrease, whereas CD19+CD5+ B-cells </text>
   <text y="714.037" x="310.016,312.518,317.018,321.014,324.011,328.007,332.003,335.504,339.5,344.0,346.394,350.39,354.89,358.886,361.388,365.888,368.138,370.037,376.535,381.035,384.536,389.036,391.538,396.038,398.54,402.536,404.93,409.43,413.93,420.932,425.432,429.428,432.425,435.926,438.32,442.82,445.817,448.211,454.709,461.207,464.204,468.2,472.196,474.698,477.2,480.701,483.095,489.593,493.589,496.586,500.582,502.976,507.476,511.976,514.478,516.872,520.868,523.703,526.7,530.696,534.692,537.194,541.19,545.69" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.25,0.25,0.72,0.5,0.39,0.5,0.28,0.5,0.28,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.39,0.25,0.5,0.33,0.25,0.72,0.72,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased again. Absolute numbers of NK-cells were not affected </text>
   <text y="725.035" x="310.016,314.516,319.016,321.662,325.658,328.16,332.156,339.158,341.66,346.16,350.156,354.656,361.658,365.654,370.154,372.8,375.302,378.299,382.295,386.291,388.793,395.795,399.791,404.291,406.793,409.043,411.689,416.693,420.689,423.686,427.682,431.678,436.178,438.68,442.676,447.176,451.172,453.818,458.318,461.315,463.961,469.964,476.462,480.962,483.959,489.962,496.46,500.96,505.46,510.536,513.182,519.68,526.178,529.175,533.171,537.167,539.669,542.171,545.672" svgx:width="0.5,0.5,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.56,0.44,0.33,0.44,0.44,0.5,0.28,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.33,0.67,0.72,0.5,0.5,0.56,0.25,0.72,0.72,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by alemtuzumab treatment. Percentage of CD3-CD56+ NK-cells </text>
  </g>
 </g>
</svg>
